Taysha Gene Therapies Inc... (TSHA)
NASDAQ: TSHA
· Real-Time Price · USD
2.92
-0.02 (-0.68%)
At close: Aug 15, 2025, 3:59 PM
2.96
1.20%
Pre-market: Aug 18, 2025, 08:07 AM EDT
TSHA Gamma Exposure By Expiry
The total Gamma Exposure (GEX) for TSHA across all expirations is 1,420.32 shares per 1% move, with 1,485.96 from calls and 65.64 from puts. The put-call GEX ratio of 0.04 shows call-heavy positioning, potentially creating volatility as market makers hedge by selling into strength and buying weakness. The highest gamma concentration is at the Oct 17, 25 expiration with 1,036 net GEX, which may act as a magnet point for price action. Near-term exposure for Sep 19, 25 suggests possible volatility from negative gamma effects.
TSHA GEX Table
| Expiry Date | Call GEX | Put GEX | Net GEX | P/C GEX |
|---|---|---|---|---|
| Sep 19, 25 | 12.59 | -15.44 | -2.85 | 1.23 |
| Oct 17, 25 | 1,050.88 | -14.88 | 1,036 | 0.01 |
| Jan 16, 26 | 373.69 | -29.61 | 344.08 | 0.08 |
| Apr 17, 26 | 0 | 0 | 0 | n/a |
| Jun 18, 26 | 3.95 | -0.21 | 3.74 | 0.05 |
| Dec 18, 26 | 44.85 | -5.5 | 39.35 | 0.12 |